[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334223-105":59,"doc-detail-334223-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","differential-infiltration-of-key-immune-t-cell-populations-across-malignancies-varying-by-immunogenic-potential-an-open-access-research-article","Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential - An Open Access Research Article","","Solid tumors differ in immunogenic potential within the tumor microenvironment and in the likelihood of response to immunotherapy. The study analyzed candidate T-cell populations and their differential infiltration across tumor types using mRNA co-expression of cellular marker genes, including stem-like TILs, TRM cells, early/late dysfunctional T-cells, APA T-cells, and BTN3A isoforms. Data covered 1892 melanoma, bladder, ovarian, and pancreatic patients and compared immune-checkpoint inhibitor survival using gene-expression patterns. Key cell densities correlated with improved outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/differential-infiltration-of-key-immune-t-cell-populations-across-malignancies-varying-by-immunogenic-potential-an-open-access-research-article/334223/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/differential-infiltration-of-key-immune-t-cell-populations-across-malignancies-varying-by-immunogenic-potential-an-open-access-research-article/334223.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To determine how key immune T-cell populations differentially infiltrate across malignancies and how this variation relates to immunogenic potential and response likelihood to immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were T-cell populations and infiltration patterns estimated?",{"text":117,"@type":113},"By analyzing mRNA co-expression levels of cellular biomarkers defining stem-like tumor-infiltrating lymphocytes, tissue-resident memory T-cells, early and late dysfunctional T-cells, APA T-cells, and BTN3A isoforms.",{"name":119,"@type":110,"acceptedAnswer":120},"Which tumor types showed significant differences in APA T-cell infiltration?",{"text":121,"@type":113},"Melanoma and bladder cancers showed significantly different estimated infiltration of APA T-cells compared with ovarian and pancreatic cancers, based on reported p-values.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334223,1790144917,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Article  \nDifferential Infiltration of Key Immune T-Cell Populations  \nAcross Malignancies Varying by Immunogenic Potential andtheLikelihood of Response to Immunotherapy  \nIslam Eljilany 1, Sam Coleman 2, Aik Choon Tan 2, Martin D. McCarter 3, John Carpten 4, Howard Colman 2,5,Abdul Rafeh Naqash 6, Igor Puzanov 7, Susanne M. Arnold 8, Michelle L. Churchman 9, Daniel Spakowicz 10,Bodour Salhia 4, Julian Marin 11, Shridar Ganesan 12, Aakrosh Ratan 13, Craig Shriver 14, Patrick Hwu 1,William S. Dalton9, George J. Weiner 15, Jose R. Conejo-Garcia 16, Paulo Rodriguez 16 and Ahmad A. Tarhini 1,16,*  \nCitation: Eljilany, I.; Coleman, S.; Tan,A.C.; McCarter, M.D.; Carpten, J.;Colman, H.; Naqash, A.R.; Puzanov, I.;Arnold, S.M.; Churchman, M.L.; et al.Differential Infiltration of Key ImmuneT-Cell Populations Across MalignanciesVarying by Immunogenic Potential andthe Likelihood of Response toImmunotherapy. Cells 2024, 13, 1993 .https://doi.org/10.3390/cells13231993  \nAcademic Editors: FábioRinaldo Santori and NataliaB. Ivanova  \nReceived: 22 October 2024  \nRevised: 21 November 2024  \nAccepted: 27 November 2024  \nPublished: 3 December 2024  \nCopyright: © 2024 by the authors.Licensee MDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license (https://creativecommons.org/licenses/by/  \n4.0/) .  \n1 Departments of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA  \n2 Huntsman Cancer Institute, Salt Lake City, UT 84132, USA  \n3 University of Colorado Cancer Center, Aurora, CO 80045, USA  \n4 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA  \n5 Department of Neurosurgery, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA  \n6 Oklahoma University Health Stephenson Cancer Center, Oklahoma City, OK 73104, USA  \n7 Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA  \n8 University of Kentucky Markey Cancer Center, Lexington, KY 40536, USA  \n9 Aster Insights, Hudson, FL 34667, USA  \n10 Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA  \n11 Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN 46202, USA  \n12 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA  \n13 Department of Genome Sciences, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA  \n14 Murtha Cancer Center, Walter Reed National Military Medical Center, Falls Church, VA 22042-5101, USA  \n15 Department of Internal Medicine, Carver College of Medicine, University of Iowa Health Care,Iowa City, IA 52242, USA  \n16 Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA  \n* Correspondence: ahmad.tarhini@moffitt.org; Tel.: +1-813-745-8581  \nAbstract: Background: Solid tumors vary by the immunogenic potential of the tumor microen-vironment (TME) and the likelihood of response to immunotherapy. The emerging literature hasidentified key immune cell populations that significantly impact immune activation or suppres-sion within the TME. This study investigated candidate T-cell populationsand their differentialinfiltration within different tumor types as estimated from mRNA co-expression levels of the cor-responding cellular markers. Methods: We analyzed the mRNA co-expression levels of cellularbiomarkers that define stem-like tumor-infiltrating lymphocytes (TILs), tissue-resident memoryT-cells (TRM), early dysfunctional T-cells, late dysfunctional T-cells, activated-potentially anti-tumor(APA) T-cells and Butyrophilin 3A (BTN3A) isoforms, utilizing clinical and transcriptomic data from1892 patients diagnosed with melanoma, bladder, ovarian, or pancreatic carcinomas. Real-worlddata were collected under the Total Cancer Care Protocol andthe Avatar® project (NCT03977402)across 18 cancer centers. Furthermore, we compared the survival ou","cbCaimVI7206Uuvb","https://ap.wps.com/l/cbCaimVI7206Uuvb","pdf",1750430,16,"English","# Introduction\n# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To determine how key immune T-cell populations differentially infiltrate across malignancies and how this variation relates to immunogenic potential and response likelihood to immunotherapy.\"},{\"question\":\"How were T-cell populations and infiltration patterns estimated?\",\"answer\":\"By analyzing mRNA co-expression levels of cellular biomarkers defining stem-like tumor-infiltrating lymphocytes, tissue-resident memory T-cells, early and late dysfunctional T-cells, APA T-cells, and BTN3A isoforms.\"},{\"question\":\"Which tumor types showed significant differences in APA T-cell infiltration?\",\"answer\":\"Melanoma and bladder cancers showed significantly different estimated infiltration of APA T-cells compared with ovarian and pancreatic cancers, based on reported p-values.\"}]","Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential - An Open Access Research Article | PDF",1790005826]